Last reviewed · How we verify

NCT06739525

Effects of Blue of Glasses VS Standard Lenses on Contrast Sensitivity & Visual Fatigue in Myopic & Non-Myopic Adults

Active, enrolled NA Last updated 18 December 2024
What this trial tests

NA trial testing Blue Light-Blocking Glasses (Intervention Group) in Myopia in 64 participants. Participants enrolled and being followed up; not accepting new ones.

Timeline
28 February 2024
Primary endpoint
1 August 2024
31 January 2025

Quick facts

Lead sponsorSuperior University
PhaseNA
StatusActive, enrolled
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingnone
Primary purposehealth services research
Enrollment64
Start date28 February 2024
Primary completion1 August 2024
Estimated completion31 January 2025
Sites1 location across Pakistan

Drugs / interventions tested

Conditions studied

Sponsor

Superior University

Who can join

Adults 18 to 50, any sex, with Myopia. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study investigates the effects of blue light-blocking glasses compared to standard lenses on contrast sensitivity and visual fatigue in myopic and non-myopic adults. With the growing use of digital screens, blue light exposure has raised concerns due to potential eye strain, sleep disruption, and visual fatigue.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Myopia

Currently open trials in the same condition.

Other Superior University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06739525.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing